Medical Faculty

BIU

The research of BIU focuses on neuropsychiatric, cardiometabolic and lung diseases, immunomodulatory aspects as well as Research Beyond Borders (RBB).

Boehringer Ingelheim Ulm University BioCenter (BIU)

On October 19, 2011 Prof. Dr. Gerd Schnorrenberg, Senior Vice President of Boehringer Research Germany and Prof. Dr. Karl Joachim Ebeling, at that time President Ulm University, signed the co-operation agreement of the "Public-Private-Partnership-Research Association BIU" in the presence of Theresia Bauer, Minister of Research of the State of Baden-Wuerttemberg, and Prof. Dr. Dr. Andreas Barner, Speaker of the Boehringer Ingelheim management.

The research focuses on neuropsychiatric, cardio metabolic and lung diseases, immunmodulatory aspects as well as Research Beyond Borders (RBB). The goals of the newly founded research association are the identification and characterization of new biomarkers, the analysis of misregulated signaling pathways as well as establishing new innovative preclinical and clinical concepts in translational research. The BioCenter is founded according to the structures and criteria of the well-established collaborative research centers of the German Research Foundation (DFG).

After two successful three-year funding periods, in which the BIU projects received a total of 9 Million Euros of funding from Boehringer Ingelheim, the State of Baden-Wuerttemberg and the Medical Faculty of Ulm University, a new concept for the future is currently being developed.

Current project call:

BIU 3.0 - Call for Project Submissions, 1st Call for Proposals

 

Submission deadline: 18.11.2024, 10 am

Scientists from Ulm University and Boehringer Ingelheim (BI) are eligible to apply. The prerequisite for the eligibility of projects in BIU 3.0 is the joint interest. Only project proposals that are jointly designed and implemented by one (or more) representatives of both cooperation partners will be funded.

Main projects can be funded with an average of €100,000/year for two years, pilot projects with a maximum of €40,000 for one year.

For more information, please refer to the information sheet (“Merkblatt”) and the guidelines (“Leitfäden”).

You can download the information sheet, guidelines and other required attachments below:


Contact:
Dr. Lysann Palkowitsch
Dr. Peter Seither
 

For thematic questions, please contact the respective topic leaders. You can find them here.

NEWS

Topics

Cardiometabolic Diseases

Scientists focussing on cardiometabolic diseases are strongly interested in the extensive interactions between pathologically altered metabolism and cardiovascular diseases.

Neuropsychiatric Diseases

The multidisciplinary research of the scientists at the Medical Faculty deals with neuropsychiatric diseases focusing on misdirected neuronal networks (circuits) as biological causes for neuropsychiatric symptom domains, e. g. cognition, impulsiveness, anhedonia or fear. That research includes topics such as epigenetic embossing of traumatic stressors, mechanisms of synaptic plasticity and cortical disinhibition.

Lung Diseases

In addition to cardiometabolic and neurodegenerative diseases the lung as a vital organ also forms a focal point in BIU, a unique cooperation in basic research between Ulm University and Boehringer Ingelheim.

Immunomodulation

The modulation of the immune system is gaining in importance as a fundamental biological principle in the pathogenesis of a large number of diseases. In order to use the underlying biological principles for a better understanding of disease, the newly established research field focuses on the identification and research of regulatory checkpoints in the immune response.